Literature DB >> 21487705

Effects of aging and menopause on serum interleukin-6 levels and peripheral blood mononuclear cell cytokine production in healthy nonobese women.

Oh Yoen Kim1, Jey Sook Chae, Jean Kyung Paik, Hee Sun Seo, Yangsoo Jang, Jean-Marc Cavaillon, Jong Ho Lee.   

Abstract

Inappropriate interleukin-6 production is thought to play a role in the development of several age-related conditions including atherosclerosis. This study aimed to determine whether aging affects circulating interleukin-6 (IL-6) levels. Healthy, nonobese women (n = 208, 44.5 ± 0.70 years, 22.4 ± 0.17 kg/m(2)) were categorized into four age groups (22-31, 32-41, 42-51, and 52-63 years; cross-sectional study). Cytokine levels in serum and those produced from peripheral blood mononuclear cell (PBMC) were measured. The oldest group had the highest circulating levels of IL-6 and oxidized low-density lipoprotein (ox-LDL) and higher PBMC production of IL-6, tumor necrosis factor-α (TNF-α), and interleukin-1 alpha (IL-1β). Additionally, significant interactions between age and menopause were found for serum IL-6 (P = 0.024), and TNF-α (P = 0.011) and IL-1β (P < 0.001) produced from PBMCs. Serum IL-6 levels positively correlated with age, waist-hip ratio (WHR), systolic blood pressure, circulating levels of TNF-α, IL-1β, and ox-LDL, and urinary 8-epi-prostaglandin F(2)α. Multiple stepwise regression models identified the following factors for contributing to serum IL-6 levels: serum IL-1β, menopause status, WHR, and serum TNF-α in mode I (R(2) = 0.302); serum IL-1β, age, serum TNF-α, and WHR (β = 0.197; P = 0.006) in model II (R(2) = 0.283). Sub-analysis was performed according to menopausal status. Serum IL-6 levels were positively associated with levels of IL-6, TNF-α, and IL-1β in PBMC supernatants (unstimulated) from postmenopausal women, whereas these were negatively associated in premenopausal women. In conclusion, circulating IL-6 levels may be interactively influenced by age and menopause. Additionally, estrogen deprivation after menopause may enhance PBMC cytokine production in postmenopausal women, resulting in increased IL-6 levels which are closely related to oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21487705      PMCID: PMC3312621          DOI: 10.1007/s11357-011-9244-2

Source DB:  PubMed          Journal:  Age (Dordr)        ISSN: 0161-9152


  44 in total

1.  Postmenopausal changes in serum cytokine levels and hormone replacement therapy.

Authors:  M Kamada; M Irahara; M Maegawa; Y Ohmoto; T Takeji; T Yasui; T Aono
Journal:  Am J Obstet Gynecol       Date:  2001-02       Impact factor: 8.661

2.  Oestrogens prevent the increase of human serum soluble interleukin-6 receptor induced by ovariectomy in vivo and decrease its release in human osteoblastic cells in vitro.

Authors:  G Girasole; N Giuliani; A B Modena; G Passeri; M Pedrazzoni
Journal:  Clin Endocrinol (Oxf)       Date:  1999-12       Impact factor: 3.478

3.  Impaired production of proinflammatory cytokines in response to lipopolysaccharide (LPS) stimulation in elderly humans.

Authors:  H Bruunsgaard; A N Pedersen; M Schroll; P Skinhoj; B K Pedersen
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

4.  The p66shc adaptor protein controls oxidative stress response and life span in mammals.

Authors:  E Migliaccio; M Giorgio; S Mele; G Pelicci; P Reboldi; P P Pandolfi; L Lanfrancone; P G Pelicci
Journal:  Nature       Date:  1999-11-18       Impact factor: 49.962

5.  Plasma cytokine profiles in elderly humans.

Authors:  R J Forsey; J M Thompson; J Ernerudh; T L Hurst; J Strindhall; B Johansson; B-O Nilsson; A Wikby
Journal:  Mech Ageing Dev       Date:  2003-04       Impact factor: 5.432

6.  Multiple lipid oxidation products in low density lipoproteins induce interleukin-1 beta release from human blood mononuclear cells.

Authors:  C E Thomas; R L Jackson; D F Ohlweiler; G Ku
Journal:  J Lipid Res       Date:  1994-03       Impact factor: 5.922

7.  Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.

Authors:  T Tamura; N Udagawa; N Takahashi; C Miyaura; S Tanaka; Y Yamada; Y Koishihara; Y Ohsugi; K Kumaki; T Taga
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

Review 8.  Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance.

Authors:  S E Shoelson; J Lee; M Yuan
Journal:  Int J Obes Relat Metab Disord       Date:  2003-12

Review 9.  Interleukin-6: a cytokine for gerontologists.

Authors:  W B Ershler
Journal:  J Am Geriatr Soc       Date:  1993-02       Impact factor: 5.562

10.  Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion.

Authors:  V Poli; R Balena; E Fattori; A Markatos; M Yamamoto; H Tanaka; G Ciliberto; G A Rodan; F Costantini
Journal:  EMBO J       Date:  1994-03-01       Impact factor: 11.598

View more
  26 in total

1.  Auditory and visual hallucinations after influenza vaccine: a case report.

Authors:  Stefania Antoniazzi; Carla Carnovale; Aurelio Sessa; Marta Gentili; Marco Matacena; Maurizia Punginelli; Emilio Clementi; Sonia Radice
Journal:  Ther Adv Vaccines       Date:  2016-10-21

2.  Bioavailability of phenolics from an oleuropein-rich olive (Olea europaea) leaf extract and its acute effect on plasma antioxidant status: comparison between pre- and postmenopausal women.

Authors:  R García-Villalba; M Larrosa; S Possemiers; F A Tomás-Barberán; J C Espín
Journal:  Eur J Nutr       Date:  2013-10-26       Impact factor: 5.614

3.  Cardiovascular Risk in HIV-Infected and Uninfected Postmenopausal Minority Women: Use of the Framingham Risk Score.

Authors:  Yamnia I Cortés; Nancy Reame; Cosmina Zeana; Haomiao Jia; David C Ferris; Elizabeth Shane; Michael T Yin
Journal:  J Womens Health (Larchmt)       Date:  2016-09-09       Impact factor: 2.681

4.  Estrogenic modulation of uropathogenic Escherichia coli infection pathogenesis in a murine menopause model.

Authors:  Caihong Wang; Jane W Symington; Emily Ma; Bin Cao; Indira U Mysorekar
Journal:  Infect Immun       Date:  2012-12-21       Impact factor: 3.441

5.  TTV DNA plasma load and its association with age, gender, and HCMV IgG serostatus in healthy adults.

Authors:  Mats Haloschan; Rainer Bettesch; Irene Görzer; Lukas Weseslindtner; Michael Kundi; Elisabeth Puchhammer-Stöckl
Journal:  Age (Dordr)       Date:  2014-10-05

6.  Age-dependent alterations in serum cytokines, peripheral blood mononuclear cell cytokine production, natural killer cell activity, and prostaglandin F.

Authors:  Dong Hee Lee; Minkyung Kim; Minjoo Kim; Young Ju Lee; Hye Jin Yoo; Sang-Hyun Lee; Jong Ho Lee
Journal:  Immunol Res       Date:  2017-10       Impact factor: 2.829

7.  Vaginal Estrogen Therapy Is Associated With Decreased Inflammatory Response in Postmenopausal Women With Recurrent Urinary Tract Infections.

Authors:  Melanie R Meister; Caihong Wang; Jerry L Lowder; Indira U Mysorekar
Journal:  Female Pelvic Med Reconstr Surg       Date:  2021-01-01       Impact factor: 1.913

8.  Alterations in adhesion molecules, pro-inflammatory cytokines and cell-derived microparticles contribute to intima-media thickness and symptoms in postmenopausal women.

Authors:  Nicté Figueroa-Vega; Carmen Moreno-Frías; Juan Manuel Malacara
Journal:  PLoS One       Date:  2015-05-19       Impact factor: 3.240

9.  Association of polymorphisms in FADS gene with age-related changes in serum phospholipid polyunsaturated fatty acids and oxidative stress markers in middle-aged nonobese men.

Authors:  Seul Hee Hong; Jung Hyun Kwak; Jean Kyung Paik; Jey Sook Chae; Jong Ho Lee
Journal:  Clin Interv Aging       Date:  2013-05-24       Impact factor: 4.458

10.  Proinflammatory and anti-inflammatory cytokine changes related to menopause.

Authors:  Andrei Mihai Malutan; Mihu Dan; Costin Nicolae; Mihu Carmen
Journal:  Prz Menopauzalny       Date:  2014-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.